Does Cannabis Interfere with OCD Exposure Therapy?

PostedFebruary 27, 2026

UpdatedFebruary 27, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Combining cannabis with behavioural interventions requires careful consideration. Understanding cannabis with exposure therapy for OCD is essential for optimising treatment outcomes and minimising potential interference.

Evaluating Cannabis Impact on Therapy

Exploring cannabis with exposure therapy for OCD helps patients and clinicians determine whether cannabinoid use affects the efficacy of standard behavioural treatments such as ERP.

ERP and Cannabis

Examining ERP and cannabis allows insight into how cannabis might alter the emotional response during exposure and response prevention exercises.

OCD with Behavioural Therapy and Cannabis

Considering OCD with behavioural therapy and cannabis highlights the importance of monitoring symptom changes and avoiding treatment interference that could reduce therapy effectiveness.

Treatment Interference

Understanding potential treatment interference ensures patients can safely incorporate cannabis without compromising the benefits of structured exposure exercises.

Clinical Recommendations

Medical and therapy supervision is crucial when using cannabis with exposure therapy for OCD, allowing for personalised guidance, careful monitoring, and adjustments to therapy strategies as needed.

Overall, cannabis with exposure therapy for OCD may affect treatment, so careful consideration of ERP and cannabis and vigilance regarding OCD with behavioural therapy and cannabis is necessary to maintain optimal outcomes.

If you’re exploring cannabis treatment options for obsessive-compulsive disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obsessive-Compulsive Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.